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Inhibition of kynureninase (L-kynurenine hydrolase, EC 3 . 7 . 1  .3)  by 
oestrone sulphate: an alternative explanation for abnormal results of 
tryptophan load tests in women receiving oestrogenic steroids 
BY DAVID A. BENDER A N D  DAVID WYNICK 
Courtauld Institute of Biochemistry, The Middlesex Hospital Medical School, 
London W1 P 7PN 
(Received 18 August 1980 - Accepted 24 October 1980) 
1 .  A partial purification of kynureninase (L-kynurenine hydrolase, EC 3 . 7 . 1  .3) from rat liver and a total 
resolution of the apoenzyme have been achieved. The hypothesis that conjugates of oestrogenic steroids compete 
with pyridoxal phosphate for the cofactor binding site of the enzyme, and so disturb tryptophan metabolism, 
leading to apparent vitamin B, deficiency, has been tested. 
2. Kynureninase from rat liver was partially purified, and the cofactor-free apoenzyme was prepared. Oestrone 
sulphate inhibited the enzyme uncompetitively with respect to pyridoxal phosphate, and competitively with respect 
to kynurenine, with a mean (kse) inhibitor constant (K,) of 8 2 k 6 p ~ .  
3. The addition of a saturating concentration of pyridoxal phosphate to unfractionated liver homogenates led 
to an approximately fivefold increase in kynureninase activity, indicating the presence of a relatively large amount 
of apo-kynureninase in the tissue. 
4. It is suggested that the abnormal results of tryptophan load tests in women receiving oestrogens are the result 
of inhibition of kynureninase by oestrogen conjugates, and that there is no evidence for oestrogen-induced vitamin 
Be deficiency in such cases. 
There are many reports showing abnormal tryptophan metabolism in women receiving 
oestrogenic steroids either as oral contraceptives or as menopausal hormone replacement 
therapy. Women treated with these steroids show greatly increased excretion of xanthurenic 
acid, kynurenic acid and kynurenine after administration of an oral dose of 2 g tryptophan, 
compared with the normal response to such a tryptophan load (Rose & Braidman, 1971). 
The tryptophan load test is an accepted test of vitamin B, nutritional status (Coursin, 1964), 
and the results in women receiving oral contraceptives have been widely interpreted as 
indicative of some extent of drug-induced vitamin B, deficiency or depletion, a view which 
is supported by the finding that administration of supplementary vitamin B, (in amounts 
considerably in excess of the usual daily intake) restores tryptophan metabolism to normal 
(Rose & Adams, 1972). 
It has been assumed that this apparent depletion of vitamin B, is the result of competition 
between conjugates of the steroids and pyridoxal phosphate, the metabolically-active form 
of the vitamin, for the cofactor binding sites of vitamin B,-dependent enzymes. Mason & 
Gullekson (1960) showed that a number of oestrogen sulphates inhibited kynurenine 
aminotransferase (L-kynurenine : 2-0x0-glutarate aminotransferase (cyclizing), EC 
2.6.1 .7), although they did not demonstrate the mechanism of this inhibition. Similar 
inhibition of kynureninase (L-kynurenine hydrolase, EC 3 .7 .1  .3) would account for the 
disturbances of tryptophan metabolism already discussed. 
Although the disturbances of tryptophan metabolism in response to oestrogen adminis- 
tration have been attributed to vitamin B, depletion, other indices of vitamin B, status are 
normal in women with abnormal tryptophan metabolism, which suggests that some other 
mechanism must be involved. Leklem et ul. (1975) showed that methionine metabolism was 
unaffected, despite the involvement of two pyridoxal phosphate dependent steps in its 
metabolism. Studies on plasma and erythrocyte aminotransferases in women receiving oral 
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Fig. 1. The oxidative metabolism of tryptophan. 
contraceptives have produced conflicting results with respect to the saturation of the 
enzymes with pyridoxal phosphate (Aly et al. 1971 ; Brown et al. 1975; Leklem'et al. 1975). 
Plasma concentrations of pyridoxal phosphate and urinary excretion of 4-pyridoxic acid, 
the principal metabolite of the vitamin, were also unaffected by oral contraceptives (Brown 
et al. 1975; Leklem et al. 1975). 
Rose & Braidman (1971) showed that women receiving contraceptive steroids excreted 
more W-methyl nicotinamide, an endproduct of tryptophan oxidative metabolism (Fig. l), 
than did non-users of contraceptives. This has been attributed to increased oxidation of 
tryptophan as a result of induction of the first and rate-limiting enzyme of the pathway, 
tryptophan oxygenase @-tryptophan : oxygen oxido-reductase (decyclizing) EC 
1 .13.11 . 1 1); such induction of tryptophan oxygenase by steroids is well established 
(Schimke et al. 1965). However it is difficult to attribute the increased formation of the 
endproduct of the pathway to an increase in the activity of tryptophan oxygenase if 
kynureninase, one of the intermediate enzymes, is inhibited by competition with its cofactor. 
In the present study, the interaction between apo-kynureninase and pyridoxal phosphate 
has been studied using a partially-purified preparation of the enzyme from rat liver. 
Oestrone sulphate was chosen as a readily available model oestrogen conjugate which has 
been used both as a contraceptive agent and in menopausal hormone-replacement therapy. 
Its effects on the apoenzyme-coenzyme interaction have been assessed in order to test the 
hypothesis that oestrogen conjugates lead to vitamin B, deficiency by competing with the 
coenzyme. 
METHODS 
Female Wistar rats, bred in the Courtauld Institute, were used for this study. Animals 
weighing between 400 and 500 g were killed by cervical dislocation, the livers were dissected 
out rapidly, frozen and stored at - 2 O O  until required. Liver was homogenized while still 
frozen in 2 ml0-15 M-sodium chloride/g tissue, and the homogenate centrifuged at 9000 g 
for 30 min to remove nuclei, cell debris and mitochondria. Pyridoxal phosphate was added 
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Table I .  Purijication of kynureninase (L-kynurenine hydrolase; EC 3 .7 .1  .3) from rat liver 
Specific 
activity Gmol 
anthranilic 
Percentage acid/min per Relative 
Preparation recovery mg protein) activity 
Liver homogenate (100) 11-9 (1.0) 
9OOog 100 15.5 1.4 
Heat denaturation 64.4 22.8 I .9 
Ammonium sulphate 21.1 4947 41.6 
supernatant fraction 
supernatant fraction 
pellet 
to the supernatant fraction to bring the final concentration to 1 mM, and the preparation 
heated at 60' for 5 min, cooled in ice and centrifuged at 9000 g for 30 min to remove 
denatured protein. Ice-cold saturated ammonium sulphate solution was added to the 
resulting supernatant fraction, The fraction precipitating between 45-55 % saturation was 
collected and dissolved in a volume of 0.2 M-Tris-acetate, pH 8.4, containing 0.5 mM- 
2-mercaptoethanol equivalent to one-quarter of the original homogenate volume. 
Phenylhydrazine hydrochloride was then added to a final concentration of 1 mM and the 
mixture incubated at 300 for 10 min, cooled in ice and dialysed against four changes of the 
same buffer at 4 O  to remove the free cofactor. 
Kynureninase activity was determined by the method described previously (Bender & 
Smith, 1978). The enzyme preparation was pre-incubated at pH 8-4 for 10min at 300 
together with pyridoxal phosphate and any inhibitors, then the reaction was initiated by 
the addition of kynurenine. The anthranilic acid formed was measured fluorimetrically. 
The concentration of pyridoxal phosphate in the livers used for preparation of 
kynureninase was determined by the following modification of the method of Adams (1979). 
In order to assess the amount of tissue pyridoxal phosphate that was freely diffusible, one 
sample of a homogenate of liver in 5 ml water/g was dialysed at 4O against four changes 
of distilled water, while the other was stored at 4" without dialysis, and was subsequently 
diluted to the same extent as the dialysed sample had been diluted by endosmosis. Portions 
of the homogenate (200 pl) were mixed with 200 p1 trichloroacetic acid (100 g/l), together 
with 100 pl water or 2 pM-pyridoxal phosphate as an internal standard, and heated at 50' 
for 15 min. After cooling to room temperature, 140 p1 3.3 M-dipotassium hydrogen 
phosphate and 25 pl 60 mM-sodium cyanide were added, and the samples were heated to 
50Ofor a further 25 min. Then 70 ~ 1 2 8 %  orthophosphoric acid (280 g/l) and 1 m12 M-sodium 
acetate were added and the fluorescence due to the pyridoxal phosphate-cyanide adduct was 
measured (excitation 310 nm, emi&on 418 nm). 
.. 
RESULTS 
The final enzyme preparation used for kinetic and inhibition studies was a 41-fold 
enrichment compared with the initial liver homogenate, and had a specific activity of 
495pmol anthranilic acid formed/min per mg protein. The recovery of activity and 
enrichment at each stage are shown in Table 1. 
. Dialysis of the ammonium sulphate precipitated preparation against 0.2 M-Tris-acetate, 
pH 8.4, led to insignificant loss of enzymic activity, indicating that the majority of the 
cofactor was tightly enzyme-bound. Reaction with phenylhydrazine followed by dialysis led 
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Fig. 2. Inhibition of kynureninase (L-kynurenine hydrolase; EC 3 . 7 . 1  .3) by oestrone sulphate in the 
presence of a saturating concentration of kynurenine ( 1  mM) and varying concentrations of pyridoxal 
phosphate. (0-0), No addition; (A-A), 0.085 mwoestrone sulphate; (.-@), 0.17 mwoestrone 
sulphate; (M-M), 0.34 mM-oestrone sulphate; v, rate of action. 
to a reduction to 0.8% of the initial activity, and addition of pyridoxal phosphate restored 
97% of the catalytic activity. Phenylhydrazine has been shown previously to be a potent 
inhibitor of kynureninase; the phenylhydrazone of pyridoxal phosphate has no catalytic 
activity, and does not form a Schiff base with the enzyme, so that it is readily removed by 
dialysis (Bender & Smith, 1978). 
The apo-enzyme had a Michaelis constant (K,) for L-kynurenine of 0.12 +0.01 mM in the 
presence of 50 pM-pyridoxal phosphate, and an apparent K, of 1.0 f: 0.04 prd for pyridoxal 
phosphate in the presence of 10 mw-L-kynurenine. These results are in close agreement with 
those reported by other workers (Soda & Tanizawa, 1979). 
Addition of pyridoxal phosphate to a final concentration of 1 mw led to a 5-fold increase 
in the kynureninase activity of the unfractionated liver homogenate, indicating the presence 
of a considerable amount of apo-kynureninase in the liver under normal circumstances. The 
total concentration of pyridoxal phosphate in the livers used for preparation of the enzyme 
was 5.3 & 0.2 nmol/g, of this 3.0 0.1 nmol/g was tightly protein-bound, and was not 
removed by extensive dialysis. 
Oestrone sulphate inhibited the enzyme. As can be seen from Fig. 2, this inhibition was 
primarily uncompetitive with respect to pyridoxal phosphate, in the presence of a saturating 
concentration of kynurenine. Fig. 3 shows that the inhibition was primarily competitive with 
respect to kynurenine when the enzyme had been pre-incubated with a saturating 
concentration of pyridoxal phosphate. The Dixon plots shown in Fig. 4 are again indicative 
of primarily competitive inhibition with respect to kynurenine, and give a value of 82+ 6 ,UM 
for the inhibitor constant (4) of oestrone sulphate. 
DISCUSSION 
The present study was designed to investigate the mechanism by which oestrogenic steroids 
lead to apparent vitamin B, deficiency, and in particular to test the hypothesis that 
metabolites of the steroids inhibit kynureninase by competing with the cofactor, pyridoxal 
phosphate, for the catalytic site (Mason & Gullekson, 1960). 
The results reported here are not compatible with this hypothesis, as they show 
uncompetitive inhibition of kynureninase by oestrone sulphate with respect to the cofactor, 
and competitive inhibition with respect to the substrate. 
These results support a possible alternative explanation of the disturbances of tryptophan 
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Fig. 3. Inhibition of kynureninase (L-kynurenine hydrolase; EC 3.7.1 .3) by oestrone sulphate in the 
presence of a saturating concentration (SO pu) of pyridoxal phosphate and varying concentrations of 
kynurenine. (0-O), No addition; (.-a), 0.17 mu-oestrone sulphate; (W-D), 0.34 mbi-oestrone 
sulphate; v, rate of reaction. 
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Fig. 4. a x o n  plot of the inhibition of kynureninase (L-kynurenine hydrolase; EC 3.7.1 .3) by oestrone 
sulphate in the presence of a saturating concentration of pyridoxal ,phosphate (SO p ~ )  and varying 
concentrations of kynurenine. (0-O), 0.057 mu-kynurenhe; (A-A), 0.1 1 mbi-kynure-nine; (0-D), 
0.22 m-kynurenine; (A-A), 0.46 mu-kynurenine; (m-w), 0.91 mhf-kynurenine; v ,  rate of reaction. 
metabolism that have been observed in women receiving oestrogenic steroids. Inhibition 
of kynureninase by metabolites of the steroids would result in an increase in the size of the 
liver pool of kynurenine, and hence an increase in the urinary excretion of kynurenine, even 
without the additional stress of a tryptophan load, as has been reported in women receiving 
oestrone sulphate preparations as menopausal hormone replacement therapy (Bender et al. 
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1981). At the same time, the increased concentration of kynurenine in the liver would result 
in increased formation of xanthurenic and kynurenic acids, by the action of kynurenine 
aminotransferase, an enzyme that normally has little activity, because of its relatively high 
K, (of the order of 1.8 mM; Ueno et al. 1963). However, since the inhibition of kynureninase 
by oestrone sulphate is competitive with respect to the substrate, this increase in the liver 
concentration of kynurenine would be expected to lead to relief of the inhibition, and hence 
restoration of normal flux of metabolites through the oxidative pathway (shown in Fig. l), 
albeit with an increased pool of kynurenine (and presumably also of hydroxy-kynurenine). 
The result of this would be normal synthesis of nicotinamide nucleotides, and hence normal 
excretion of W-methyl nicotinamide. Induction of the first enzyme of the pathway, 
tryptophan oxygenase, by steroids (Schimke et al. 1965) would lead to an increased flux 
of metabolites through the pathway, and hence to increased excretion of W-methyl 
nicotinamide, as has been reported (Rose & Braidman, 1971). 
The finding that tryptophan metabolism could be restored to normal in women receiving 
oral contraceptives by administration of supplements of vitamin B, has been considered 
to be evidence of a deficiency of the vitamin caused by the drugs (Rose & Adams, 1972). 
However, the finding reported here of a considerable excess of apo-kynureninase in the liver 
of the rat under normal conditions might permit an alternative explanation of the effect 
of supplementary vitamin B,; it could lead to activation of the normally-inactive 
apoenzyme to the holoenzyme, and so mask the inhibition of kynureninase by metabolites 
of the steroids. 
The concentration of pyridoxal phosphate in the liver samples that was removable by 
dialysis, and hence which might be considered to be available for interchange between 
enzymes, and for activation of apo-kynureninase, was found to be 2-3f0.01 nmol/g of 
tissue; approximately twice the apparent K,,, of kynureninase for its cofactor (1 -0 f 0-04 PM). 
Since it is to be expected that a number of apoenzymes in the liver would compete with 
one another for this free cofactor, it is not surprising that there is at least some free 
apo-kynureninase in the liver. Preliminary studies with the partially-purified preparation 
of kynureninase used here showed that a threshold concentration of pyridoxal phosphate 
was required for activation of apo-kynureninase; apparent as an extent of sigmoidicity of 
the graph of pyridoxal phosphate concentration v.  kynureninase activity. This presumably 
reflects the presence of other enzymes in the preparation with a greater affinity for the 
cofactor than that of kynureninase. 
The Ki of oestrone sulphate, 82 f 6 PM, is relatively high, although it might reasonably 
be expected that such a concentration could be achieved in the livers of women receiving 
oestrone sulphate preparations. Oestrone sulphate is not a significant human metabolite ; 
however, it is a conveniently-available model compound, and preliminary experiments 
suggest that oestrone glucuronide, which is a human metabolite, inhibits kynureninase in 
a similar manner to that reported here for oestrone sulphate, and is a more potent inhibitor. 
Unconjugated oestrone was not inhibitory. 
The results reported here do not support the accepted hypothesis for the action of 
oestrogenic steroids in leading to vitamin B, deficiency, but suggest that the effects on 
tryptophan metabolism which have been interpreted as indicative of vitamin B, deficiency 
are in fact due to a direct effect of oestrogen metabolites on kynureninase, one of the 
enzymes of tryptophan metabolism. It is therefore suggested that oestrogens do not lead 
to vitamin B, depletion, and that administration of vitamin B, supplements to women 
receiving oral contraceptives or hormone replacement therapy is probably inappropriate. 
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